Determination of the binding of a β2-blocker drug, frusemide and ceftriaxone to serum proteins by capillary zone electrophoresis
- 31 May 1997
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 15 (8) , 1033-1039
- https://doi.org/10.1016/s0731-7085(96)01888-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The binding of 5-fluorouracil to native and modified human serum albumin: UV, CD, and 1H and 19F NMR investigationJournal of Pharmaceutical and Biomedical Analysis, 1995
- HPCE as an Analytical Probe for Assessing Irreversible Ligand/Macromolecule Binding InteractionsJournal of Liquid Chromatography, 1993
- Analysis of ICI 118551, a new β2 blocking drug, and related compounds by RP-HPLC—DADJournal of Pharmaceutical and Biomedical Analysis, 1992
- Determination of free drug in protein binding equilibrium by high-performance frontal analysis using internal-surface reversed-phase silica support.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interactionLife Sciences, 1988
- Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1987
- An approach to the study of protein—drug interactions by using capillary isotachophoresisFEBS Letters, 1978
- The effect of electroconvulsive shock on the cerebral metabolism of dopamine and 5-hydroxytryptamineJournal of Pharmacy and Pharmacology, 1968
- Measurement of protein-binding phenomena by gel filtrationBiochimica et Biophysica Acta, 1962
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949